Making the Impossible Possible
Platform to develop clonal iPSC-derived organoids

Adoption of iPSC-derived organoids has been limited to relatively low throughput applications, as the workflows are hampered by challenges in reproducibility and scalability, as well as being manually intensive.

Reimagine your iPSC-derived organoid assays

• Track and trace growth and differentiation of hundreds of iPSC-derived organoids




• Fully automate isolation of individual viable, intact organoids of interest




• Generate customized 96-well plates for organoid-based assays, such as clonal propagation, drug or toxicity screening, or target discovery

With the CellRaft Technology, we have shown how to increase the generation and reproducibility of iPSC-derived organoids.

Take a look at the newly released application note to answer the following questions:

• How can iPSCs be reliably differentiated into tissue-specific organoids?




• What is the best protocol for developing clonal organoids?




• Can the differentiation of individual organoids be monitored over time?

Relevant for your research? Download the App Note to improve your research pursuits: